Boston is one of the leading clusters for biotech innovation and drug discovery in the country, perhaps the world. For many it is certainly the best place in the world to launch a biotech company. Boston’s biotech growth has been explosive and made out region the epicenter of drug discovery. Moderna and Pfizer certainly solidified this recognition by being the first companies in the world to find a vaccine for COVID-19.

We think this is the most exciting phase of any project.

The planning is all complete and now the real action happens! The execution phase is often the longest phase of any project.

It was a year like no other, and one that saw just about everyone who could, working remotely. That experience had some good points and bad points.

One of the upsides (besides not having to commute) was that for the most part, productivity did not decline. People worked just as much, and sometimes significantly more, from their homes as they did when they came into the office. We all became adept at zooming instead of gathering in conference rooms.

No one here at Hereva was surprised when Moderna won the prestigious ISPE Facility of the Future Award for their cGMP clinical manufacturing facility in Norwood, MA.

Hereva was chosen by Moderna to be Owner’s Representative and oversee the design, construction and finish of what was a 1970’s era manufacturing site, turning it into a state-of-the-art facility comprised of multiple, flexible cGMP suites for mRNA clinical manufacturing.